人福医药(600079)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

600079 人福医药

已收盘 11-22 15:00:00

{"stockData":{"symbol":"600079","market":"SH","secType":"STK","nameCN":"人福医药","latestPrice":22.49,"timestamp":1732258800000,"preClose":23.8,"halted":0,"volume":19172500,"delay":0,"floatShares":1543000000,"shares":1632000000,"eps":1.1981,"marketStatus":"已收盘","marketStatusCode":5,"change":-1.31,"latestTime":"11-22 15:00:00","open":23.79,"high":23.84,"low":22.49,"amount":441000000,"amplitude":0.0567,"askPrice":22.49,"askSize":4330,"bidPrice":22.48,"bidSize":125,"shortable":0,"etf":0,"ttmEps":1.1981,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732498200000},"adr":0,"adjPreClose":23.8,"symbolType":"stock","openAndCloseTimeList":[[1732239000000,1732246200000],[1732251600000,1732258800000]],"highLimit":26.18,"lowLimit":21.42,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1632225965,"pbRate":2.05,"roa":"--","roe":"9.02%","epsLYR":1.32,"committee":-0.910626,"marketValue":36709000000,"floatMarketCap":34706000000,"peRate":18.771388,"changeRate":-0.055,"turnoverRate":0.0124,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2024-11-25。"},"requestUrl":"/m/hq/s/600079","defaultTab":"news","newsList":[{"id":"2485286032","title":"人福医药跌5% 16家券商看好","url":"https://stock-news.laohu8.com/highlight/detail?id=2485286032","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485286032?lang=zh_cn&edition=full","pubTime":"2024-11-22 14:42","pubTimestamp":1732257758,"startTime":"0","endTime":"0","summary":"11月22日，人福医药股价大幅下跌，截至14点42分，人福医药下跌5.04%，报22.60元/股，成交4.00亿元，换手率1.13%。此外，数据统计显示，近半年内1家券商给予增持建议，15家券商给予买入建议。资金动向截止发稿，人福医药获得主力净流出1565万元，其中超大单流出218万元，大单流出1345万元。最新财报显示，今年三季报，人福医药实现营业收入191.43亿元，同比增长5.70%，净利润为15.90亿元，同比减少10.12%，基本每股收益为0.98元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122144434abd69c43&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122144434abd69c43&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0070","BK0185","BK0012","600079","BK0028","BK0188","BK0096","BK0239"],"gpt_icon":0},{"id":"2485561154","title":"人福医药：11月21日召开董事会会议","url":"https://stock-news.laohu8.com/highlight/detail?id=2485561154","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485561154?lang=zh_cn&edition=full","pubTime":"2024-11-21 16:22","pubTimestamp":1732177356,"startTime":"0","endTime":"0","summary":"每经AI快讯，人福医药 11月21日晚间发布公告称，公司第十届第七十二次董事会会议于2024年11月21日以通讯表决方式召开。2023年1至12月份，人福医药的营业收入构成为：医药占比53.05%，医药批发及相关业占比46.05%。人福医药的董事长是李杰，男，69岁，学历背景为本科；总裁是邓霞飞，男，61岁，学历背景为博士。截至发稿，人福医药市值为388亿元。道达号“个股趋势”提醒：1. 近30日内无机构对人福医药进行调研。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121162345abd42c98&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121162345abd42c98&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0185","BK0239","BK0028","BK0070","600079","BK0096","BK0188","BK0012"],"gpt_icon":0},{"id":"2484866187","title":"人福医药涨5% 医疗器械业向好","url":"https://stock-news.laohu8.com/highlight/detail?id=2484866187","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484866187?lang=zh_cn&edition=full","pubTime":"2024-11-20 09:39","pubTimestamp":1732066752,"startTime":"0","endTime":"0","summary":"消息解读2024年我国医疗器械产业形势总体向好，高质量发展取得新成效，产业正在加速走向高端化。主营业务及业绩人福医药公司主营业务为医药、医疗器械、生殖健康等产品及技术的研发、生产、销售及技术服务。最新财报显示，今年三季报，人福医药实现营业收入191.43亿元，同比增长5.70%，净利润为15.90亿元，同比减少10.12%，基本每股收益为0.98元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120093957a24727b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120093957a24727b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159883","BK0070","600079","BK0028","BK0239","BK0188","BK0096","BK0185","BK0012"],"gpt_icon":0},{"id":"2484317645","title":"人福医药董事长李杰减持1073万股 总额2.03亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484317645","media":"财中社","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484317645?lang=zh_cn&edition=full","pubTime":"2024-11-18 17:01","pubTimestamp":1731920489,"startTime":"0","endTime":"0","summary":"因2020年发行股份购买资产形成的纳税义务，李杰计划在2024年7月27日披露的减持公告后，通过集中竞价或大宗交易方式减持不超过1200万股，占公司总股本的0.74%。截至本公告披露日，李杰实际累计减持公司股份1073万股，占公司总股本的0.66%。目前，李杰仍持有8675万股，占公司总股本的5.31%。2024年前三季度，人福医药实现收入191.43亿元，归母净利润15.90亿元。文章来源：财中社人福医药董事长李杰减持1073万股，总额2.03亿元","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118170929abcc0bda&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118170929abcc0bda&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0096","BK0028","BK0070","600079","BK0185","BK0239","BK0188","BK0012"],"gpt_icon":0},{"id":"2484648808","title":"人福医药(600079.SH)董事长累计减持0.66%股份 减持期满","url":"https://stock-news.laohu8.com/highlight/detail?id=2484648808","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484648808?lang=zh_cn&edition=full","pubTime":"2024-11-18 16:30","pubTimestamp":1731918624,"startTime":"0","endTime":"0","summary":"智通财经APP讯，人福医药(600079.SH)发布公告，截至本公告披露之日，董事长李杰本次减持计划的减持时间区间届满，李杰累计减持公司股份1073.29万股，占公司总股本的比例为0.66%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1212218.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0070","600079","BK0028","BK0239","BK0188","BK0096","BK0185","BK0012"],"gpt_icon":0},{"id":"2484619072","title":"人福医药11月18日主力资金流入1629万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2484619072","media":"市场透视","labels":["Business Data"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484619072?lang=zh_cn&edition=full","pubTime":"2024-11-18 15:18","pubTimestamp":1731914308,"startTime":"0","endTime":"0","summary":"11月18日, 人福医药股价跌2.98%，报收22.80元，成交金额6.38亿元，换手率1.78%，振幅5.15%，量比0.87。人福医药今日主力资金净流入1629万元，连续3日净流入，上一交易日主力净流入3286万元，今日环比减少50.43%。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为50.00%，平均涨幅为0.96%。该股近5个交易日上涨4.35%，主力资金累计净流入7773万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入3.47亿元，其中净流入天数为15日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118152237abcb9d05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118152237abcb9d05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","BK0188","600079","BK0070","BK0185","BK0239","BK0096","BK0012"],"gpt_icon":0},{"id":"2484576485","title":"华源证券：给予人福医药买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2484576485","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484576485?lang=zh_cn&edition=full","pubTime":"2024-11-17 09:55","pubTimestamp":1731808516,"startTime":"0","endTime":"0","summary":"华源证券股份有限公司刘闯,李强近期对人福医药进行研究并发布了研究报告《股东重整临近，有望迎来戴维斯双击》，本报告对人福医药给出买入评级，当前股价为23.5元。我们选取恩华药业、海思科和恒瑞医药作为可比公司，公司估值水平低于可比公司，首次覆盖给予“买入”评级。最新盈利预测明细如下：该股最近90天内共有8家机构给出评级，买入评级8家；过去90天内机构目标均价为28.77。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111700000249.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600079","161027"],"gpt_icon":0},{"id":"2483360084","title":"人福医药创10个月新高 获主力净流入2914万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483360084","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483360084?lang=zh_cn&edition=full","pubTime":"2024-11-15 10:25","pubTimestamp":1731637510,"startTime":"0","endTime":"0","summary":"11月15日，人福医药股价大幅上涨，截至10点25分，人福医药上涨5.21%，报23.83元/股，创近10个月新高，成交3.55亿元，换手率0.99%，振幅6.00%。资金动向截止发稿，人福医药获得主力净流入2914万元，其中超大单流入1071万元，大单流入1843万元。数据显示，该股今日净流入较近5日净流入均值增加1784万元。最新财报显示，今年三季报，人福医药实现营业收入191.43亿元，同比增长5.70%，净利润为15.90亿元，同比减少10.12%，基本每股收益为0.98元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115102523abc2d3e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115102523abc2d3e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0188","600079","BK0070","BK0185","BK0096","BK0012","BK0239","BK0028"],"gpt_icon":0},{"id":"2482232597","title":"人福医药11月12日获主力加仓2823万元 环比增加588.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482232597","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482232597?lang=zh_cn&edition=full","pubTime":"2024-11-12 15:18","pubTimestamp":1731395938,"startTime":"0","endTime":"0","summary":"11月12日, 人福医药股价涨1.97%，报收22.28元，成交金额8.65亿元，换手率2.51%，振幅4.62%，量比1.71。人福医药今日主力资金净流入2823万元，连续6日净流入，上一交易日主力净流入410万元，今日环比增加588.54%。近一年数据显示，该股主力连续6日净流入后，次日上涨概率为50.00%，平均涨幅为3.33%。该股近5个交易日上涨4.80%，主力资金累计净流入1.09亿元，其中2个交易日为股价下跌时净流入；近20日主力资金累计净流入2.28亿元，其中净流入天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112152534abb8fb1b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112152534abb8fb1b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0012","BK0028","BK0239","BK0096","BK0185","600079","BK0070","BK0188"],"gpt_icon":0},{"id":"2482273813","title":"人福医药11月11日主力资金流入410万元 连续5日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2482273813","media":"市场透视","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482273813?lang=zh_cn&edition=full","pubTime":"2024-11-11 15:18","pubTimestamp":1731309534,"startTime":"0","endTime":"0","summary":"11月11日, 人福医药股价跌0.23%，报收21.85元，成交金额4.77亿元，换手率1.42%，振幅3.24%，量比1.05。人福医药今日主力资金净流入410万元，连续5日净流入，上一交易日主力净流入2384万元，今日环比减少82.80%。近一年数据显示，该股主力连续5日净流入后，次日上涨概率为50.00%，平均涨幅为3.11%。该股近5个交易日上涨3.21%，主力资金累计净流入8379万元，其中2个交易日为股价下跌时净流入；近20日主力资金累计净流入1.87亿元，其中净流入天数为11日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111152246a22bb088&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111152246a22bb088&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","BK0188","BK0096","BK0239","BK0012","BK0185","BK0070","600079"],"gpt_icon":0},{"id":"2482846568","title":"人福医药 大股东重整取得进展 核心业务稳健增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2482846568","media":"投资快报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482846568?lang=zh_cn&edition=full","pubTime":"2024-11-09 07:25","pubTimestamp":1731108315,"startTime":"0","endTime":"0","summary":"2024年第三季度营业收入62.82亿元，同比增长9.66%，归母净利润4.79亿元，同比增长7.57%，扣非归母净利润4.32亿元，同比增长0.04%。根据相关法律法规规定，重整方案有望明年上半年确定。公司核心子公司宜昌人福2024年前三季度实现营业收入67.7亿元，同比增长13%，实现归母净利润17.4亿元，同比增长20%，继续保持稳健增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109073532a225af0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109073532a225af0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600079","BK0239","BK0188","BK0185","BK0096","BK0012","BK0028","BK0070"],"gpt_icon":0},{"id":"2481926225","title":"研报掘金丨海通证券：人福医药控股股东重整投资人已有进展，予“优于大市”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2481926225","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481926225?lang=zh_cn&edition=full","pubTime":"2024-11-07 16:03","pubTimestamp":1730966636,"startTime":"0","endTime":"0","summary":"格隆汇11月7日｜海通证券研报指出，人福医药(600079.SH)控股股东重整投资人已有进展，公司收入稳中有增。第三季度营业收入62.82亿元(同比增长9.66%)，归母净利润达4.79亿元(同比增长7.57%)。截至2024年10月22日，共有6家重整投资人通过了形式审查且已完成报名保证金的缴纳，成为合格报名重整投资人暨取得投资人竞选资格。参考可比公司估值，考虑公司所处的麻醉药行业的稳定性及其领先地位，给予公司2024年15-19倍PE，对应合理价值区间20.02-25.36 元，给予“优于大市”评级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107160359aba941ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107160359aba941ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600079"],"gpt_icon":0},{"id":"2481947425","title":"人福医药11月07日主力资金流入3869万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2481947425","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481947425?lang=zh_cn&edition=full","pubTime":"2024-11-07 15:17","pubTimestamp":1730963831,"startTime":"0","endTime":"0","summary":"11月07日, 人福医药股价涨1.95%，报收21.97元，成交金额4.87亿元，换手率1.44%，振幅4.18%，量比1.20。人福医药今日主力资金净流入3869万元，连续3日净流入，上一交易日主力净流入1366万元，今日环比增加183.24%。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为46.15%，平均涨幅为0.79%。该股近5个交易日上涨1.95%，主力资金累计净流入5501万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入1.30亿元，其中净流入天数为9日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107151748a21f796f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107151748a21f796f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0185","BK0012","600079","BK0096","BK0188","BK0028","BK0239","BK0070"],"gpt_icon":0},{"id":"2481869964","title":"人福医药大幅上涨 获主力净流入3534万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481869964","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481869964?lang=zh_cn&edition=full","pubTime":"2024-11-06 10:01","pubTimestamp":1730858479,"startTime":"0","endTime":"0","summary":"11月06日，人福医药股价大幅上涨，截至10点01分，人福医药上涨5.03%，报22.33元/股，成交2.79亿元，换手率0.84%，振幅6.16%。资金动向截止发稿，人福医药获得主力净流入3534万元，其中超大单流入3291万元，大单流入242万元。数据显示，该股今日净流入较近5日净流入均值增加3478万元。最新财报显示，今年三季报，人福医药实现营业收入191.43亿元，同比增长5.70%，净利润为15.90亿元，同比减少10.12%，基本每股收益为0.98元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106100219aba396fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106100219aba396fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0070","600079","BK0028","BK0239","BK0188","BK0096","BK0185","BK0012"],"gpt_icon":0},{"id":"2481406662","title":"人福医药（600079）11月5日主力资金净买入329.31万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481406662","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481406662?lang=zh_cn&edition=full","pubTime":"2024-11-06 08:28","pubTimestamp":1730852901,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年11月5日收盘，人福医药报收于21.26元，上涨0.43%，换手率1.22%，成交量18.84万手，成交额3.99亿元。11月5日的资金流向数据方面，主力资金净流入329.31万元，占总成交额0.82%，游资资金净流出1.35万元，散户资金净流出327.96万元，占总成交额0.82%。融券方面，融券卖出4700.0股，融券偿还6500.0股，融券余量13.32万股，融券余额283.18万元。人福医药主营业务：药品的研发、生产和销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110600008256.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0012","BK0188","600079","BK0070","BK0096","BK0239","BK0185"],"gpt_icon":0},{"id":"2481078579","title":"太平洋：给予人福医药买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2481078579","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481078579?lang=zh_cn&edition=full","pubTime":"2024-11-05 19:05","pubTimestamp":1730804721,"startTime":"0","endTime":"0","summary":"太平洋证券股份有限公司近期对人福医药进行研究并发布了研究报告《人福医药：大股东重整取得进展，核心业务稳健增长》，本报告对人福医药给出买入评级，当前股价为21.26元。对应EPS分别为1.35/1.58/1.86元，对应当前股价PE分别为16/13/11倍，维持“买入”评级。最新盈利预测明细如下：该股最近90天内共有8家机构给出评级，买入评级8家；过去90天内机构目标均价为34.6。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110500031703.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601099","600079"],"gpt_icon":0},{"id":"2481452516","title":"医药巨头人福医药遭证监会立案，涉嫌信披违规或可索赔","url":"https://stock-news.laohu8.com/highlight/detail?id=2481452516","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481452516?lang=zh_cn&edition=full","pubTime":"2024-11-05 11:45","pubTimestamp":1730778300,"startTime":"0","endTime":"0","summary":"　　按照申万行业分类，广济药业（维权）属于医药生物-化学制药-化学制剂。　　艾路明先生通知，艾路明先生于2023年8月7日收到中国证券监督管理委员会《立案告知书》，因涉嫌信息披露违法违规，公司控股股东非经营性资金占用未及时披露。　　2024年10月22日，公司收到中国证券监督管理委员会《立案告知书》，因涉嫌信息披露违法违规被立案调查。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/gmwq/rightscase/2024-11-05/doc-incuyrey2344111.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/gmwq/rightscase/2024-11-05/doc-incuyrey2344111.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1515","BK0185","BK0012","600079","09939","BK0096","159938","BK0188","BK1161","BK0028","BK1574","BK0239","BK0070"],"gpt_icon":0},{"id":"2481859592","title":"人福医药遇到多项大事件，股价持续走低","url":"https://stock-news.laohu8.com/highlight/detail?id=2481859592","media":"证券市场周刊","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481859592?lang=zh_cn&edition=full","pubTime":"2024-11-05 10:09","pubTimestamp":1730772540,"startTime":"0","endTime":"0","summary":"与此同时，人福医药同期还正面临着三季报不及预期、控股股东重整等大事件。10月23日，人福医药公告称，公司及控股股东武汉当代科技产业集团股份有限公司于10月22日收到中国证监会下发的《立案告知书》，因涉嫌信息披露违法违规，中国证监会决定对公司及控股股东当代科技立案。23日的另一份公告显示，人福医药已由于相关违法行为，受到了监管层的处罚。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105101119a2167b84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105101119a2167b84&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0188","600079","BK0070","BK0185","BK0096","BK0012","BK0239","BK0028"],"gpt_icon":0},{"id":"2479253771","title":"开源证券：给予人福医药买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2479253771","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479253771?lang=zh_cn&edition=full","pubTime":"2024-10-31 16:59","pubTimestamp":1730365177,"startTime":"0","endTime":"0","summary":"开源证券股份有限公司余汝意,刘艺近期对人福医药进行研究并发布了研究报告《公司信息更新报告：收入稳健增长，核心麻醉业务表现亮眼》，本报告对人福医药给出买入评级，当前股价为21.55元。最新盈利预测明细如下：该股最近90天内共有8家机构给出评级，买入评级8家；过去90天内机构目标均价为29.29。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103100032775.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600079","161027"],"gpt_icon":0},{"id":"2479377695","title":"人福医药最新公告：复方醋酸钠林格注射液获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2479377695","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479377695?lang=zh_cn&edition=full","pubTime":"2024-10-31 16:24","pubTimestamp":1730363071,"startTime":"0","endTime":"0","summary":"人福医药公告，控股子公司宜昌人福近日收到国家药品监督管理局核准签发的复方醋酸钠林格注射液的《药品注册证书》。复方醋酸钠林格注射液用于循环血量及组织间液减少时的细胞外液的补充，代谢性酸中毒的纠正。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103100031455.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0028","BK0239","BK0096","BK0185","600079","BK0070","BK0188"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"1997-06-06","address":"湖北省武汉市洪山区东湖高新区高新大道666号","stockEarnings":[{"period":"1week","weight":-0.043},{"period":"1month","weight":0.0122},{"period":"3month","weight":0.1535},{"period":"6month","weight":0.1802},{"period":"1year","weight":-0.0284},{"period":"ytd","weight":-0.0648}],"companyName":"人福医药集团股份公司","boardCode":"AI0027","perCapita":"36888股","boardName":"医药制造业","registeredCapital":"163222万元","compareEarnings":[{"period":"1week","weight":-0.0191},{"period":"1month","weight":-0.0108},{"period":"3month","weight":0.1446},{"period":"6month","weight":0.0577},{"period":"1year","weight":0.0671},{"period":"ytd","weight":0.0982}],"survey":"　　人福医药集团股份公司的主营业务为药品的研发、生产和销售。公司主要产品为药品、医疗器械。公司是湖北省医药工业龙头企业和国家技术创新示范企业。公司连续14年入选国家工信部“中国医药工业百强榜”，入选“2023中国制造业企业500强”、“2023中国制造业民营企业500强”榜单。","serverTime":1732350879697,"listedPrice":5.22,"stockholders":"41834人(较上一季度减少11.45%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"人福医药(600079)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供人福医药(600079)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"人福医药,600079,人福医药股票,人福医药股票老虎,人福医药股票老虎国际,人福医药行情,人福医药股票行情,人福医药股价,人福医药股市,人福医药股票价格,人福医药股票交易,人福医药股票购买,人福医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"人福医药(600079)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供人福医药(600079)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}